A lentiviral vector manufactured under GMP for a Phase I study in Acute Myeloid Leukaemia - manufacture summary, safety testing, application and post-administration safety-monitoring (2012)

First Author: Chan Lucas
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 23

Parent Publication: HUMAN GENE THERAPY

Issue: 5

ISSN: 1043-0342